Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Comparative Study of Modified Release (MR) Tacrolimus/Mycophenolate Mofetil (MMF) in de Novo Kidney Transplant Recipients

ClinicalTrials.gov ID: NCT00064701

Public ClinicalTrials.gov record NCT00064701. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 8:28 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Randomized, Open-Label, Comparative, Multi-Center Study to Assess the Safety and Efficacy of Prograf (Tacrolimus)/MMF, Modified Release (MR) Tacrolimus/MMF and Neoral (Cyclosporine)/MMF in de Novo Kidney Transplant Recipients

Study identification

NCT ID
NCT00064701
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Astellas Pharma Inc
Industry
Enrollment
668 participants

Conditions and interventions

Interventions

  • Tacrolimus Modified Release (MR) Drug
  • Tacrolimus Drug
  • cyclosporine microemulsion Drug
  • mycophenolate mofetil Drug

Drug

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2003
Primary completion
Feb 28, 2005
Completion
Feb 28, 2009
Last update posted
Dec 4, 2013

2003 – 2009

United States locations

U.S. sites
48
U.S. states
23
U.S. cities
39
Facility City State ZIP Site status
Not listed Birmingham Alabama 35294
Not listed Mobile Alabama 36617
Not listed Loma Linda California 92354
Not listed Los Angeles California 90033
Not listed Los Angeles California 90057
Not listed Los Angeles California 90058
Not listed Los Angeles California 90095-7306
Not listed Palo Alto California 94304
Not listed San Diego California 92103
Not listed San Diego California 92123
Not listed San Francisco California 94115
Not listed Denver Colorado 80262
Not listed Washington D.C. District of Columbia 20010
Not listed Gainesville Florida 32610-0224
Not listed Jacksonville Florida 32216
Not listed Augusta Georgia 30912
Not listed Chicago Illinois 60612
Not listed Chicago Illinois 60637
Not listed Indianapolis Indiana 46202
Not listed Lexington Kentucky 40536
Not listed New Orleans Louisiana 70112
Not listed New Orleans Louisiana 70121
Not listed Boston Massachusetts 02214
Not listed Ann Arbor Michigan 48109-0364
Not listed Detroit Michigan 48202
Not listed Livingston New Jersey 07039
Not listed New Brunswick New Jersey 08901
Not listed Albany New York 12208
Not listed Buffalo New York 14203
Not listed New York New York 10029
Not listed Valhalla New York 10595
Not listed Chapel Hill North Carolina 27599-7211
Not listed Durham North Carolina 27710
Not listed Cincinnati Ohio 45267
Not listed Portland Oregon 97210
Not listed Portland Oregon 97239-2940
Not listed Harrisburg Pennsylvania 17104
Not listed Philadelphia Pennsylvania 19104
Not listed Philadelphia Pennsylvania 19107
Not listed Nashville Tennessee 37212-4750
Not listed Dallas Texas 75235
Not listed Dallas Texas 75246
Not listed Houston Texas 77030
Not listed San Antonio Texas 78229-3900
Not listed Salt Lake City Utah 84132
Not listed Fairfax Virginia 22031
Not listed Madison Wisconsin 53792-7375
Not listed Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 9 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00064701, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 4, 2013 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00064701 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →